Abstract
In present study it is aimed to radiolabel vincristine with 99mTc and to evaluate bioaffinity of 99mTc labeled vinc. The optimum conditions required to obtain 99.6 ± 0.4 %, (n = 5) radiolabeling yield of 99mTc-vincristine (99mTc-vinc) were as follows: pH 4, 5 µg of vincristine sulphate, 6 µg SnCl2·2H2O as a reducing agent and 10 min incubation time at room temperature. Quality control of 99mTc-vinc was done by using paper electrophoresis and thin layer chromatography. The radiolabeling yield was confirmed by High performance liquid chromatography using radioactive and UV detector operating at 230 nm. 99mTc-vinc was stable in vitro for 5 h. Biodistribution and scintigraphy of 99mTc-vinc was performed in mice and rabbits respectively and that 99mTc-vinc showed high uptake of it in liver and spleen. Finally 99mTc-vinc may be the potential imaging agent for liver and spleen.
Similar content being viewed by others
References
Becker W (1995) The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med 10:1195–1211
Oliva MR, Saini S (2004) Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging. doi:10.1102/1470-7330.2004.0011
El-Ghany EA, Amine AM, El-Sayed AS, El-Kolaly MT, Abdel-Gelil F (2005) Radiochemical and biological characteristics of 99mTc-piroxicam for scintigraphy of inflammatory lesions. J Radioanal Nucl Chem 266(1):125–130
Hina S, Rajoka MI, Roohi S, Haque A, Qasim M (2014) Preparation, biodistribution, and scintigraphic evaluation of 99mTc-clindamycin: an infection imaging agent. Appl Biochem Biotechnol 174:1420–1433
Zahoor R, Roohi S, Ahmad M, Iqbal Z, Amir N, Tariq S, Savage PB (2013) Synthesis of 99mTc-cationic steroid antimicrobial-107 and in vitro evaluation. J Radioanal Nucl Chem 295:841–844
Amir N, Roohi S, Pervez S, Mushtaq A, Jehangir M, Miyashita Y, Okamoto K (2009) S-bridged complex of 99mTc with fac (S)-[Rh(aet)3]. Quality control, characterization and biodistribution studies in rats. J Radioanal Nucl Chem 279(1):25–30
Qaiser SS, Khan MR (2013) Synthesis and biological evaluation of the 99mTc-gemifloxacin dithiocarbamate complex: a novel Streptococcus pneumoniae infection imaging agent. J Mol Imaging Dyn 2(2):1–4
Faheem AR, Bokhari TH, Roohi S, Mushtaq A, Sohaib M (2013) 99mTc-Daunorubicin a potential brain imaging and theranostic agent: synthesis, quality control, characterization, biodistribution and scintigraphy. Nucl Med Biol 40:148–152
Faheem AR, Bokhari TH, Roohi S, Chem M (2012) A direct labeling of doxorubicin with technetium-99m: its optimization, characterization and quality control. J Radioanal Nucl 293:303–307
Altiparmak B, Lambrecht FY, Bayrak E, Durkan K (2010) Design and synthesis of 99m Tc-citro-folate for use as a tumor-targeted radiopharmaceutical. J Pharm 400:8–14
Sakr TM, Essa BM, El-Essawy FA, El-Mohty AA (2014) Synthesis and biodistribution of 99m Tc-PyDA as a potential marker for tumor hypoxia imaging. Radiochemistry 56:76–80
Zhang Y, Stevenson GD, Barber C, Furenlid LR, Barrett HH, Woolfenden JM, Zhao M, Liu Z (2013) Imaging of rat cerebral ischemia-reperfusion injury using 99mTc-labeled duramycin. Nucl Med Biol 40:80–88
Xu YP, Luo SN, Pan DH, Wang LZ, Zhou YR, Yang M (2013) Synthesis and preliminary evaluation of 99mTc-spermine as a tumor imaging agent. J Radioanal Nucl Chem 295:1861–1866
Amin AM, Sanad MH, Abd-Elhaliem SM (2013) Radiochemical and biological characterization of 99m Tc-piracetam for brain imaging. Radiochemistry 55(6):624–628
Gelfand M, Parisi M, Treves S (2011) Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med 52:318–322
Norenberg JP, Hladik WB, Henkin RE (2006) Nuclear medicine, 2nd edn. Mosby Elsevier, Philadelphia, pp 938–948
Bartholoma MD, Louie AS, Valliant ZF, Zubieta J (2010) Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era. Chem Rev 110:2903–2920
Sanad MH, El-Tawoosy M (2013) Labeling of ursodeoxycholic acid with technetium-99m for hepatobiliary imaging. J Radioanal Nucl Chem 298:1105–1109
Blaha V, Cihak I, Nicek F (1993) Clearance and distribution parameters of 99mTc-EHIDA, -DTPA and -MAG-3 by dynamic liver/kidney scintigraphy. Nucl Med Biol 20:89–93
Kula M, Karacavus S, Baskol M, Deniz K, Abdulrezzak U, Tutus A (2010) Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation. Nucl Med Commun 31:280–285
Malhi H, Bhargava KK, Afriyie MO, Volenberg I, Schilsky LM, Palestro CJ, Gupta S (2002) 99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson’s disease. J Nucl Med 43(2):246–252
Shen S, Jacob R, Bender LW, Duan J, Spencer SA (2014) A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases. Med Dosim 39:7–11
Shah I, Bhatnagar S, Rangarajan V, Patankar N (2012) Utility of Tc-99m-mebrofenin hepato-biliary scintigraphy (HIDA scan) for the diagnosis of biliary atresia. Trop Gastroenterol 33:62–64
Lan JA, Chervu LR, Johansen KL, Wolkoff AW (1988) Uptake of technetium 99m hepatobiliary imaging agents by cultured rat hepatocytes. Gastroenterology 95:1625–1631
Ayoub SM, Abu Taleb AM, Ebeid NH (2014) Radiolabeling of alpha-fetoprotein monoclonal antibody for detection of liver tumor. Radiochemistry 56:81–85
Xiangting C, Qiaoyu L, Wenyu S, Feng Z, Xuehao W, Hai W (2012) Bromocriptine enhances the uptake of 99mTc-MIBI in patients with hepatocellular carcinoma. J Biomed Res 26:165–169
de Barros ALB, das Grac¸as Mota L, de Aguiar Ferreira C, Correˆa NCR, de Go´es AM, Oliveira MC, Cardoso VN (2013) 99m Tc-labeled bombesin analog for breast cancer identification. J Radioanal Nucl Chem 295:2083–2090
Oates E, Austin JM, Becker JL (1995) Technetium-99m-sulfur colloid SPECT imaging in infants with suspected heterotaxy syndrome. J Nucl Med 36:1368–1371
Pohlson EC, Wilkinson RW, Witzum KF (1994) Heat damaged red cell scan for intraoperative localization of the accessory spleen. J Pediatr Surg 29:604–608
Johnson IS, Armstrong JG, Gorman M, Burnett JP (1963) The vinca alkaloids: a new class of oncolytic agents. Cancer Res 23:1390–1427
Qweider M, Gilsbach JM, Rohde V (2007) Inadvertent intrathecal vincristine administration: a neurosurgical emergency: case report. J Neurosurg 6:280–283
Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD (1996) Severe vincristine neuropathy in charcot-marie-tooth disease type 1A. Cancer 7:1356–1362
Chen X, Li L, Liu F, Liu B (2006) Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. Bioorg Med Chem Lett 16:5503–5506
Saha GB (2003) Fundamentals of nuclear pharmacy, 5th edn. Springer, New York
Colledge D, Civitico G (2000) In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir. Antimicrob Agents Chemother 44(3):551–560
Acknowledgments
The authors are thankful to Mr. Ibrar Haider, Zafar, Riaz and Jamshed for their helpful discussions and providing facilities to work properly in lab.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hina, S., Roohi, S., Rajoka, M.I. et al. Preparation, quality control and biological characterization of 99mTc-vincristine. J Radioanal Nucl Chem 304, 553–561 (2015). https://doi.org/10.1007/s10967-014-3836-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-014-3836-0